000 01746 a2200457 4500
005 20250516053028.0
264 0 _c20120508
008 201205s 0 0 eng d
022 _a1873-4995
024 7 _a10.1016/j.jconrel.2011.08.015
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSandoval, Michael A
245 0 0 _aEGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activity.
_h[electronic resource]
260 _bJournal of controlled release : official journal of the Controlled Release Society
_cJan 2012
300 _a287-96 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aAnimals
650 0 4 _aAntimetabolites, Antineoplastic
_xadministration & dosage
650 0 4 _aCell Line, Tumor
650 0 4 _aDeoxycytidine
_xadministration & dosage
650 0 4 _aEpidermal Growth Factor
_xadministration & dosage
650 0 4 _aErbB Receptors
_xmetabolism
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aNanoparticles
_xadministration & dosage
650 0 4 _aNeoplasms
_xmetabolism
650 0 4 _aOvalbumin
_xadministration & dosage
650 0 4 _aTumor Burden
_xdrug effects
650 0 4 _aGemcitabine
700 1 _aSloat, Brian R
700 1 _aLansakara-P, Dharmika S P
700 1 _aKumar, Amit
700 1 _aRodriguez, B Leticia
700 1 _aKiguchi, Kaoru
700 1 _aDigiovanni, John
700 1 _aCui, Zhengrong
773 0 _tJournal of controlled release : official journal of the Controlled Release Society
_gvol. 157
_gno. 2
_gp. 287-96
856 4 0 _uhttps://doi.org/10.1016/j.jconrel.2011.08.015
_zAvailable from publisher's website
999 _c21114017
_d21114017